We have compared three techniques for the detection of plasma circulat
ing antiplatelet antibodies, i.e., the platelet suspension immunofluor
escence test (PSIFT), the platelet radioactive antiglobulin test (PRAT
), and the monoclonal antibody immobilization of platelet antigens (MA
IPA). Frozen plasma samples from patients with idiopathic thrombocytop
enic purpura or HIV-associated thrombocytopenia were used in the study
. The PSIFT and PRAT showed the appropriate ease of performance necess
ary for screening purposes. The PSIFT is free of radioactivity hazards
, but seemed to be less sensitive than the PRAT. The MAIPA is a useful
tool to detect antibodies against glycoproteins (GPs) Ib/IX and IIb/I
IIa. However, in comparison to PSIFT and PRAT, MAIPA is more time cons
uming, requires considerable technical expertise, and the identificati
on of antiplatelet activity is highly dependent on the selection of an
appropriate primary anti-GP monoclonal antibody. This could explain t
he lower prevalence of antiplatelet activity detected by MAIPA, in com
parison to the frequency provided by the PSIFT and PRAT.